- Registration to 2014 Foundation Scheme Pilot opens on Monday, March 24, 2014; Details below.
- The V Foundation for Cancer Research – V Scholar Program (final reminder; application dates & details updated)
- Transplantation Research Foundation of BC – Venture Grant Competition
- United States Pharmacopeial Convention – Global Fellowship Awards
- Government of Canada – Banting Postdoctoral Fellowships
- Alex’s Lemonade Stand – Bio-Therapeutics Impact Grant
- Centre for Blood Research – Seminar Series: RasGRPs: Important Regulators of Ras in Lymphocytes and Potential Drug Targets in Mantle Cell Lymphoma
- Centre for Blood Research – 2014 Norman Bethune Symposium (reminder, 1 attachment)
Registration to the 2014 Foundation Scheme 1st Live Pilot competition will open this Monday, March 24, 2014 and will close on June 23, 2014. CIHR has incorporated an extended registration period for this competition to allow additional time for planning as we transition to the new scheme. Complete registration instructions can be found online.
Information on all Program Leaders involved in the application will be collected, however please note that the Program Leader who opens the Foundation registration in their ResearchNet account will be identified as the one who is administratively responsible for the grant. The Program Leader will need to confirm their eligibility to apply to this competition, eligibility that will be validated by CIHR.
Applicants will be required to indicate the estimated budget amount they intend to request for the full 7 year term (5 years for New/Early-career investigators). CIHR acknowledges that details on the Foundation Scheme budget module have not been finalized, but we are in the process of developing the module and it will be shared as soon as possible.
Applicants are encouraged to estimate a budget amount that would be appropriate to support their proposed program of research, taking into consideration their previous CIHR funding history. However, we would like to emphasize that at this stage, applicants are required to provide an estimate only. They are not required to provide any justification and applicants may change their budget request at Stage 2. CIHR is collecting information at the registration stage for administrative purposes only to help with planning.
If you have any questions please contact Roadmap-Plan.Strategique@cihr-irsc.gc.ca.
UBC Internal deadline: 1pm on March 25, 2014
The V Foundation for Cancer Research has invited The University of British Columbia to nominate one young scientist (Assistant Professor level – see eligibility requirements (3.)) to this year’s V Scholar Award Program competition (http://www.jimmyv.org/research/VSCHOLARgrant/). This is the first year that the V Foundation has invited nominations from non-USA based cancer research institutions. Funding is available for laboratory-based fundamental and translational research. Each grant will total $200,000, and is given in two annual installments. The application is due to the V Foundation by April 7th.
Note that only one individual from UBC will be selected to apply.
Please see The V Foundation for details on timelines, the application process, and eligibility.
LOI Deadline: May 1, 2014
The Wall Solutions Initiative supports innovative research projects aimed towards practical solutions to societal problems. In situations where a large part of the research has been completed, the objective may be to develop innovative ways to overcome issues of implementation or adoption into practice. Proposals must demonstrate active participation with a proposed community or end-user partner. Solutions projects may apply for up to $50,000. Larger budgets may be considered if partner contributions are available. Institute staff will work with applicants to identify potential funding partners.
Registration Deadline: May 1, 2014
The Transplant Research Foundation (TRF) of BC has announced their 2014 / 2015 Venture Grant Competition for support of innovative projects across British Columbia that have the potential to have significant impact on organ transplantation. The intent of the Venture Grant competition is to fund new areas of research (e.g., new hypotheses, techniques, or ideas) that are in a pilot/feasibility stage, and which will lead to external peer reviewed funding to support the next stages of research. Projects related pediatric organ transplantation are encouraged.
For more information and to register, please visit the TRF website.
Deadline: May 2, 2014
The United States Pharmacopeial Convention is a scientific nonprofit organization that sets standards for the identity, strength, quality, and purity of medicines, food ingredients, and dietary supplements manufactured, distributed, and consumed worldwide. USP’s drug standards are enforceable in the United States by the Food and Drug Administration and are used in more than a hundred and forty countries.
The USP Global Fellowship Awards program promotes research in areas relating to standards for medicines, foods, and dietary supplements and their use. Since its inception in 1981, the program has invested nearly $4 million in more than two hundred fellowship awards.
Grants of up to $50,000 will be awarded to students whose proposed research directly addresses a specific USP scientific or research need. The program offers up to three years of funding. Applicants must ensure that their research topic is in close alignment to USP research priorities.
To be eligible, applicants must have been accepted for full-time study in a Ph.D. or Pharm.D. program, or medical or dental school; have been accepted to a fellowship program; or have been awarded a postdoctoral research (non-faculty) appointment.
Visit the USP Web site for complete program guidelines and application instructions.
UBC Internal deadline: June 9, 2014
The Postdoctoral Fellows Office is pleased pleased to inform you that the information for UBC’s internal selection process and full details for the prestigious Banting Postdoctoral Fellowship are now available on the PDFO Website. NOTE: internal selection process is only for candidates interested in holding their fellowship at UBC.
With its internationally competitive level of funding and as Canada’s most prestigious trainee competition, the Banting Postdoctoral Fellowship is one of the most sought-after fellowship opportunities for PDFs. The objective of the Banting Postdoctoral Fellowship Program is to attract and retain top-tier postdoctoral talent, both nationally and internationally, to develop their leadership potential and to position them for success as research leaders of tomorrow. Hosting a Banting PDF within your Faculty or Department is highly beneficial toward a rich research environment, and having Banting PDFs at UBC raises the university’s profile and reputation as a top research institution.
For full details on the UBC internal selection and application process, please visit the PDFO website.
NOTE: This information is only for candidates interested in holding their fellowship at UBC.
Deadline: June 12, 2014
Alex’s Lemonade Stand Foundation is excited to offer our new Bio-Therapeutics Impact Grant. This grant aims to accelerate the development of clinical trials for promising biologic approaches to treating childhood cancer. These approaches include, but are not limited to, immunotherapy, gene therapy and small molecules. The award, intended for investigators who are initiating clinical trials or undertaking the pre-clinical work necessary to move into the IND (investigational new drug) phase, totals the maximum of $1.5 million awarded over three years.
Guidelines for the Bio-Therapeutics Impact Grant are available at the foundation’s website.
Centre for Blood Research – Seminar Series: RasGRPs: Important Regulators of Ras in Lymphocytes and Potential Drug Targets in Mantle Cell Lymphoma
Date & Time: March 26, 2014, 12-1pm
Location: LSC 3, Life Sciences Centre, 2350 Health Sciences Mall, Vancouver
Dr. James Stone
Department of Biochemistry
University of Alberta
The small GTPase Ras plays a key role in governing cell proliferation, differentiation and viability. In lymphocytes, Ras is regulated by two types of Ras guanyl exchange factors: Sos and RasGRP. RasGRP family members have a catalytic domain similar to Sos. They also have calcium-binding EF hands and diacylglycerol (DAG)-binding C1 domains. In T cells and B cells, RasGRPs act to couple immune receptor signaling, phospholipase C activation and DAG/calcium messengers to Ras signaling.
RasGRPs in lymphocytes are potently activated by DAG analogues. Non-tumor promoting DAG analogues have been investigated as possible anti-cancer agents. Accordingly, we used a “disease discovery” approach to identify lymphocyte malignancies that might respond to DAG analogue stimulation of RasGRP pathways linked to cell death. Although our studies are limited by the use of cell lines, results indicate that certain cases of B non-Hodgkin’s lymphoma, including mantle cell lymphoma, might benefit from DAG analogue therapy.
Date & Time: April 9, 2014
Location: SFU Segal Building, 500 Granville Street, Vancouver BC
Please see attached 2014 Norman Bethune Symposium poster for details.